| Net Cash Provided by (Used in) Operating Activities |
-26.6K |
USD |
+77.9% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
20.8K |
USD |
-83.4% |
Q3 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
250M |
shares |
0% |
Q1 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
125M |
shares |
+24% |
Q1 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-5.82K |
USD |
-219% |
Q3 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
-100% |
Q1 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
2.21M |
USD |
+4.55% |
Q2 2024 |
FY 2023 |
| Deferred Tax Assets, Gross |
2.21M |
USD |
+4.55% |
Q2 2024 |
FY 2023 |
| Deferred Tax Assets, Operating Loss Carryforwards |
1.29M |
USD |
+7.6% |
Q2 2024 |
FY 2023 |
| Additional Paid in Capital |
11.1M |
USD |
+6.02% |
Q1 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2024 |
FY 2023 |